Swiss orthopedics company Medacta International and Geisinger Health System have said they will pilot a lifetime guarantee program for knee replacement surgeries. The program will cover full costs for screened Geisinger Health Plan members who receive knee replacement surgery while also ensuring reimbursement for any associated future care the patients may incur throughout their lifetimes. Medacta and Geisinger will […]
Medacta IPO on track for Q2
Swiss medical device maker Medacta Group is reportedly on track for an initial public offering during the second quarter. The company would issue a limited amount of shares into public trading, maintaining the founding Siccardi family’s control intact, according to Reuters. The IPO would also include an over-allotment option, the newswire reported. Rumors of the […]
Report: Medacta readies for Swiss IPO
Swiss medtech company Medacta is preparing for an initial public offering on the SIX Swiss Exchange for next spring, according to a Reuters report. The deal is being led by Credit Suisse and Morgan Stanley and joined by JP Morgan and UBS, three people familiar with the matter told Reuters. Neither the company or the […]
GE replaces CEO Flannery with ex-Danaher chief Culp | Personnel Moves – October 1, 2018
General Electric (NYSE:GE) said today it named former Danaher (NYSE:DHR) prez and CEO H. Lawrence Culp Jr. as its chair and CEO, replacing John Flannery, effective immediately. The Boston-based company said that alongside the switch in the corner office, it does not expect it will meet its guidance for free cash flow and earnings per share for […]
7 medtech stories we missed this week: May 25, 2018
From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance […]
13 orthopedic products from AAOS 2018 you need to know
The American Academy of Orthopedic Surgeons’s annual meeting is an opportunity for industry professional to come together and showcase some of their latest orthopedic solutions, research and technology. The meeting is being held in New Orleans at the Morial Convention Center, March 6-10. This year, a number of orthopedic companies have launched some of their latest […]
Medacta wins FDA nod for 3DMetal knee revision implants
Medacta said today it won FDA clearance for its 3DMetal tibial cones designed for knee revision surgery. The first procedures with the device were recently performed by Dr. Kevin Hardt and device designer Dr. David Manning of Chicago’s Northwestern University Feinberg School of Medicine and Dr. Dragan Jeremic of Brakel, Germany’s St. Vincenz Krankenhaus, the Switzerland-based […]
Medacta wins FDA nod for anatomic, reverse shoulder repair components
Medacta said today it won FDA clearance for its Anatomic shoulder and reverse shoulder components designed as part of its Medacta shoulder system) The Chicago-based company touted that the 1st successful procedure using the device was recently performed at Northwestern Memorial Hospital by Dr. Matthew Saltzman who is also a fan of Shoulder MD. “The […]
7 medtech stories we missed this week: Oct. 20, 2017
From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime […]
Medacta International acquires Vivamed
Medacta International has announced its acquisition of the Austrian distributor Vivamed. The acquisition went into effect on Feb. 1. Medacta, a privately held and family-owned global designer of joint replacement and spinal surgery products, hopes to strengthen its presence in Austria and facilitate future development and investments in the market with this acquisition. It also […]
Teva Pharma CEO Vigodman steps down | Personnel Moves | February 7, 2017
Teva Pharmaceuticals (NYSE:TEVA) said this week that CEO Erez Vigodman has stepped down from their position at the head of the world’s biggest generic drugmaker. Vigodman’s exit from the company will take effect immediately, with board chair Yitzhak Peterburg taking on the interim role of chief exec. Israel-based Teva has seen shares plummet after a series of […]
